Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-07

Clinical Trial Update: Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) [Phase 2]

View source ↗

Summary

A Phase 2 trial (OLTRAD STUDY) is evaluating oleanolic acid as a therapeutic adjuvant for type 2 diabetes mellitus; the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oleanolic acid (oleanolic acid)

Snippet

Sponsor: Spanish National Research Council | Conditions: Diabetic Patients, Type II Diabetes Mellitus | Phase 2 | Status: ACTIVE_NOT_RECRUITING